Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Serum concentration and excretion of H3Y digitoxin in humans under normal and pathologic conditions].

Literature DB >> 5382549

[Serum concentration and excretion of H3Y digitoxin in humans under normal and pathologic conditions].

H Lahrtz, H M Reinold, P A van Zwieten.

Abstract

Entities: Chemical Gene Species

Mesh：

Substances：

Year: 1969 PMID： 5382549 DOI： 10.1007/bf01881619

Source DB: PubMed Journal: Klin Wochenschr ISSN： 0023-2173

× No keyword cloud information.

17 in total

1. STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

Authors: J E DOHERTY; W H PERKINS; M C WILSON
Journal: Am J Med Date: 1964-10 Impact factor: 4.965

2. DISTRIBUTION IN PLASMA, UPTAKE BY THE HEART AND EXCRETION OF OUABAIN-H3 IN HUMAN SUBJECTS.

Authors: B H MARKS; S DUTTA; J GAUTHIER; D ELLIOTT
Journal: J Pharmacol Exp Ther Date: 1964-09 Impact factor: 4.030

3. STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS.

Authors: J E DOHERTY; W H PERKINS
Journal: Am J Cardiol Date: 1965-02 Impact factor: 2.778

4. Blood level studies of C14-digitoxin in human subjects with cardiac failure.

Authors: G T OKITA; P J TALSO; J H CURRY; F D SMITH; E M GEILING
Journal: J Pharmacol Exp Ther Date: 1955-04 Impact factor: 4.030

5. Metabolic fate of radioactive digitoxin in human subjects.

Authors: G T OKITA; P J TALSO; J H CURRY; F D SMITH; E M GEILING
Journal: J Pharmacol Exp Ther Date: 1955-12 Impact factor: 4.030

6. [Determination of protein binding of different cardiac glycosides by means of Sephadex gel filtration].

Authors: K Kuschinsky
Journal: Naunyn Schmiedebergs Arch Exp Pathol Pharmakol Date: 1968

7. The influence of kidney or liver disorders on the serum concentration and urinary excretion of 3H-peruvoside, a tritium-labelled cardiac glycoside.

Authors: H Lahrtz; P A van Zwieten
Journal: Eur J Pharmacol Date: 1968-05 Impact factor: 4.432

8. Excretion of radioactive digitoxin by the dog.

Authors: B G Katzung; F H Meyers
Journal: J Pharmacol Exp Ther Date: 1965-08 Impact factor: 4.030

9. Studies with tritiated digoxin in anephric human subjects.

Authors: J E Doherty; W J Flanigan; W H Perkins; G L Ackerman
Journal: Circulation Date: 1967-02 Impact factor: 29.690

10. [On the tissue distribution, metabolism and excretion of cardiac glycosides].

Authors: P A van Zwieten
Journal: Dtsch Med Wochenschr Date: 1967-09-15 Impact factor: 0.628

7 in total

1. Serum concentration and urinary excretion of 3 H-ouabain and 3 H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism.

Authors: W Eickenbusch; H Lahrtz; U Seppelt; P A van Zwieten
Journal: Klin Wochenschr Date: 1970-03-01

[Serum concentration and excretion of H3Y digitoxin in humans under normal and pathologic conditions].

1. STUDIES WITH TRITIATED DIGOXIN IN RENAL FAILURE.

2. DISTRIBUTION IN PLASMA, UPTAKE BY THE HEART AND EXCRETION OF OUABAIN-H3 IN HUMAN SUBJECTS.

3. STUDIES FOLLOWING INTRAMUSCULAR TRITIATED DIGOXIN IN HUMAN SUBJECTS.

4. Blood level studies of C14-digitoxin in human subjects with cardiac failure.

5. Metabolic fate of radioactive digitoxin in human subjects.

6. [Determination of protein binding of different cardiac glycosides by means of Sephadex gel filtration].

7. The influence of kidney or liver disorders on the serum concentration and urinary excretion of 3H-peruvoside, a tritium-labelled cardiac glycoside.

8. Excretion of radioactive digitoxin by the dog.

9. Studies with tritiated digoxin in anephric human subjects.

10. [On the tissue distribution, metabolism and excretion of cardiac glycosides].

1. Serum concentration and urinary excretion of 3 H-ouabain and 3 H-digitoxin in patients suffering from hyperthyroidism or hypothyroidism.

2. [The elimination of alpha-acetyldigoxin and k-strophanthin in renal insufficiency].

Review 3. Clinical pharmacokinetics of cardiac glycosides in patients with renal dysfunction.

Review 4. Disease-related alterations in cardiac glycoside disposition.

Review 5. Digitalis pharmacokinetics and therapy with respect to impaired renal function.

6. Metabolism of digitoxin in man and its modification by spironolactone.

7. Digitoxin and its metabolites in patients with liver cirrhosis.